Cargando…
A clinical evaluation of amlexanox oral adhesive pellicles in the treatment of recurrent aphthous stomatitis and comparison with amlexanox oral tablets: a randomized, placebo controlled, blinded, multicenter clinical trial
BACKGROUND: Amlexanox has been developed as a 5 percent topical oral paste for the treatment of patients with recurrent aphthous stomatitis (RAS) in most European countries. However, it is not yet available in China and has not been generally accepted in clinical treatment. The aim of this study was...
Autores principales: | Meng, Wenxia, Dong, Yi, Liu, Jie, Wang, Zhi, Zhong, Xiaobo, Chen, Ruiyang, Zhou, Hongmei, Lin, Mei, Jiang, Lu, Gao, Feng, Xu, Tao, Chen, Qianming, Zeng, Xin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2690593/ https://www.ncbi.nlm.nih.gov/pubmed/19419555 http://dx.doi.org/10.1186/1745-6215-10-30 |
Ejemplares similares
-
Effectiveness of Amlexanox and Adcortyl
for the treatment of recurrent aphthous ulcers
por: Abbasi, Farid, et al.
Publicado: (2016) -
Assessment of Efficacy of 5% Topical Amlexanox and 0.1% Topical Triamcinolone Acetonide in Management of Recurrent Aphthous Stomatitis
por: Kavita, Kumari, et al.
Publicado: (2020) -
Assessment of the Effectiveness of Aloe vera Versus Amlexanox in the Treatment of Recurrent Aphthous Ulcers: A Three-Arm Placebo-Controlled Randomized Clinical Trial
por: Yousef, Nasem Jamal, et al.
Publicado: (2022) -
Rescue of nonsense mutations by amlexanox in human cells
por: Gonzalez-Hilarion, Sara, et al.
Publicado: (2012) -
Amlexanox Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss
por: Zhang, Yong, et al.
Publicado: (2015)